close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar53Point11
Implied share price

Sell Overvalued by 41.8%

5% margin of safety What's this?

EV / EBITDA
Use Average
AGN
Allergan, Inc.
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
NVO
Novo Nordisk A/S (ADR)
Change
AMGN
Amgen, Inc.
Change
8.77 15.5 17.08 4.63 3.06 7.26
All amounts in millions
from last financial year
         
Implied Share Price $53.11 $50.35 $72.67 $359.03 $85.04
Market Cap 28,083 100,042 92,468 63,865 54,595
Net Debt -986 -3,369 11,280 -16,649 787
Enterprise Value (EV) 26,728 96,673 56,670 76,452 55,382
Revenue 5,419 13,418 35,058 66,346 15,582
EBITDA 1,724 5,661 12,249 24,983 7,627
Percent 31.8 % 42.2 % 34.9 % 37.7 % 48.9 %
EBIT 1,471 5,069 7,674 22,493 6,568
Percent 27.1 % 37.8 % 21.9 % 33.9 % 42.2 %
Balance Sheet          
Total Assets 8,508 21,787 100,165 64,698 48,871
Total Liabilities 3,199 6,116 43,946 27,250 29,842
Shareholders Equity 5,309 15,671 56,219 37,448 19,029.0

Price history

Comments

No comments yet. Login to comment.